ebomi
Colour theme
Sign in
Insider · CIK 0001778307

Cheng Andrew

CIK 0001778307 Name as filed on the most recent filing

Filed as Cheng Andrew (47)

101 transaction lines · from 47 filings · filed 2021-07-06 to 2025-10-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

101 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-10-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 30,000 disposed 53.98 1,619,340.00 Form 4, filing 0001193125-25-239343
2025-09-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,796 disposed 43.02 77,263.92 Form 4, filing 0000950170-25-114661
2025-09-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 22,525 disposed 42.99 968,439.85 Form 4, filing 0000950170-25-114661
2025-09-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,317 disposed 44.00 321,911.42 Form 4, filing 0000950170-25-114661
2025-09-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 158 disposed 44.62 7,049.96 Form 4, filing 0000950170-25-114661
2025-08-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 18,805 disposed 48.86 918,906.32 Form 4, filing 0000950170-25-108232
2025-08-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 10,795 disposed 48.07 518,915.65 Form 4, filing 0000950170-25-108232
2025-08-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 400 disposed 49.44 19,774.00 Form 4, filing 0000950170-25-108232
2025-07-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 15,314 disposed 51.73 792,223.85 Form 4, filing 0000950170-25-095409
2025-07-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 14,686 disposed 50.57 742,671.02 Form 4, filing 0000950170-25-095409
2025-06-18 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6,620 disposed 54.84 363,040.80 Form 4, filing 0000950170-25-088641
2025-06-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 15,158 disposed 54.35 823,882.77 Form 4, filing 0000950170-25-085674
2025-06-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 14,842 disposed 53.76 797,905.92 Form 4, filing 0000950170-25-085674
2025-06-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,837 disposed 53.99 423,150.98 Form 4, filing 0000950170-25-085674
2025-05-12 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 22,800 disposed 41.63 949,255.20 Form 4, filing 0000950170-25-070811
2025-05-12 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,200 disposed 41.00 295,200.00 Form 4, filing 0000950170-25-070811
2025-04-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 30,000 disposed 35.23 1,056,780.00 Form 4, filing 0000950170-25-053391
2025-03-12 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,738 disposed 44.88 78,001.44 Form 4, filing 0000950170-25-039765
2025-03-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 28,784 disposed 41.75 1,201,616.86 Form 4, filing 0000950170-25-038177
2025-03-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,216 disposed 42.31 51,452.61 Form 4, filing 0000950170-25-038177
2025-02-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 12,640 disposed 51.75 654,145.28 Form 4, filing 0000950170-25-018311
2025-02-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 9,972 disposed 53.67 535,157.35 Form 4, filing 0000950170-25-018311
2025-02-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6,439 disposed 52.91 340,674.61 Form 4, filing 0000950170-25-018311
2025-02-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 749 disposed 54.55 40,854.95 Form 4, filing 0000950170-25-018311
2025-02-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 200 disposed 55.81 11,162.00 Form 4, filing 0000950170-25-018311
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 24,242 disposed 54.56 1,322,643.52 Form 4, filing 0000950170-25-010705
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 3,377 disposed 56.89 192,117.53 Form 4, filing 0000950170-25-010705
2025-01-27 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 2,381 disposed 55.53 132,216.93 Form 4, filing 0000950170-25-010705
2024-12-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,855 disposed 30.79 241,855.45 Form 4, filing 0000950170-24-136017
2024-12-02 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 25,000 disposed 32.09 802,250.00 Form 4, filing 0000950170-24-133435
2024-11-01 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 81,280 disposed 31.47 2,558,044.16 Form 4, filing 0000950170-24-121100
2024-11-01 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 27,086 disposed 32.50 880,267.91 Form 4, filing 0000950170-24-121100
2024-10-18 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 63,313 disposed 31.53 1,996,068.95 Form 4, filing 0000950170-24-115731
2024-10-18 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 226 disposed 32.12 7,259.12 Form 4, filing 0000950170-24-115731
2024-10-17 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 3,103 disposed 31.12 96,559.15 Form 4, filing 0000950170-24-115731
2024-10-16 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 24,992 disposed 31.14 778,150.91 Form 4, filing 0000950170-24-115731
2024-09-10 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,738 disposed 26.18 45,500.84 Form 4, filing 0000950170-24-106451
2024-06-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,894 disposed 22.64 178,728.05 Form 4, filing 0000950170-24-073181
2024-03-13 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,969 disposed 28.33 55,781.77 Form 4, filing 0000950170-24-032263
2024-03-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 35,827 disposed 31.40 1,124,974.97 Form 4, filing 0000950170-24-027510
2024-03-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 14,680 disposed 34.63 508,372.80 Form 4, filing 0000950170-24-027510
2024-03-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 9,614 disposed 33.83 325,266.62 Form 4, filing 0000950170-24-027510
2024-03-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,995 disposed 35.49 283,775.33 Form 4, filing 0000950170-24-027510
2024-03-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6,770 disposed 32.28 218,537.63 Form 4, filing 0000950170-24-027510
2024-03-04 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 114 disposed 36.28 4,135.92 Form 4, filing 0000950170-24-027510
2023-12-14 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 1,628 disposed 20.76 33,797.28 Form 4, filing 0000950170-23-071242
2023-12-11 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 7,405 disposed 20.02 148,272.54 Form 4, filing 0000950170-23-069504
2023-12-08 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 12,873 disposed 20.01 257,570.71 Form 4, filing 0000950170-23-069504
2023-12-07 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 6,700 disposed 20.02 134,125.29 Form 4, filing 0000950170-23-069504
2023-10-02 Akero Therapeutics, Inc.
AKRO 		S, Open-market sale 8,868 disposed 46.06 408,433.48 Form 4, filing 0000950170-23-052057

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 101
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Cheng Andrew, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001778307

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.